Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

S&P Biotech SPDR (NY: XBI )

83.75 +1.53 (+1.86%)
Streaming Delayed Price Updated: 2:08 PM EDT, Apr 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,405,450
Open 82.58
Bid (Size) 83.75 (4)
Ask (Size) 83.76 (9)
Prev. Close 82.22
Today's Range 81.63 - 83.87
52wk Range 63.80 - 103.52
Shares Outstanding 776,000
Dividend Yield 0.00%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
Many fortunes have been made with a fortuitous investment in a biotech stock at the right time. That time might be now. 
Via InvestorPlace
Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead
Healthcare stocks disappointed again last week with the XLV down over 3% and up only 1.65 % YTD, in a continued downtrend since March 28. 
Via Talk Markets

Performance

YTD
-7.18%
-7.18%
1 Month
-9.65%
-9.65%
3 Month
-5.37%
-5.37%
6 Month
+26.55%
+26.55%
1 Year
+5.55%
+5.55%

More News

Read More
Clean Energy, Semiconductors Among Interest-Rate-Sensitive Sectors Hammered Thursday Afternoon On Rate Cut Concerns
Via Benzinga
Topics Economy
Exposures Interest Rates
5 Healthcare Stocks to Buy for 2024
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
AskSlim Market Week - Friday, March 28
Via Talk Markets
Healthcare And Biotech Stocks Review: Q1 2024 Performance
Via Talk Markets
Topics Stocks
Exposures US Equities
2 Top Biotech Buyout Candidates
Via Talk Markets
3 Top ETFs I Plan to Buy in April
Via The Motley Fool
Topics ETFs
3 Biotech Stocks to Buy on the Dip: March 2024
Via InvestorPlace
Tuesday Talk: Big-Tech Under Attack
Via Talk Markets
Biotechnology And Healthcare, A Bit Of A Lull
Via Talk Markets
3 Biotech ETFs Overdue for a Bounce
Via InvestorPlace
Topics ETFs
It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
Via Talk Markets
Are We Listening To The Market's Message?
Via Talk Markets
Topics ETFs Economy
Exposures Economy
“Advance Is Advancing” Stock Market (And Sentiment Results)…
Via Talk Markets
Topics Economy
Exposures Economy Interest Rates
Biotech Stocks Surge To Start 2024: 'Charts Look Great,' But Will The Trend Continue?
Via Benzinga
TG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares?
Via Investor's Business Daily
Opportunities For Investors Beyond AI And Nvidia – Biotech Breaks Out, New GDP Data Shows Inflation Pressure
Via Benzinga
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
ETF Theme: Range-Bound
Via Talk Markets
Topics ETFs
Healthcare Stocks Are Looking Better But What About Biotech?
Via Talk Markets
Favoring IWM, XBI, And KRE
Via Talk Markets
Sunday ETF Review, Feb. 4, 2024
Via Talk Markets
Topics ETFs
Biotech And Medtech Portfolio Notes On A Fed Day
Via Talk Markets
Topics Economy
Exposures Interest Rates
3 Biotech Stocks with Potential for Major Medical Breakthroughs in 2024
Via InvestorPlace
Momentum Shifts Back To Tech Stocks As Healthcare Lags In 2024
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.